Acosta, L, Soldevila, N, Torner, N, Avellón, A, Hernando, V, Borràs, E, Martínez, A, Pericas, C, Rius, C, Godoy, P, Domínguez, A. Modelling Hepatitis B virus related hospital discharges in Spain: ARIMAX based liver disease forecasting tool for hospital workload and mortality progression. PLoS One. 2026; 21(6)DOI:10.1371/journal.pone.0329751. PMID:42335072. IF:2.600(Q2/4D).

Corriveau-Lecavalier, N, Falgàs, N, Putcha, D, Graff-Radford, J, Yong, KXX, Boon, BDC, Mohanty, R, Westman, E, Groot, C, Jones, DT, Grinberg, LT, Rabinovici, GD, Whitwell, JL, Apostolova, LG, Murray, ME, Hammers, DB, Schindler, SE, Atonsdottir, I, Rhodus, EK, Schott, JM, Illán-Gala, I, Chukwuanugo, O, Guerra, JJL, Peters, R, Abner, EL, Abdelnour, C, Lladó, A, La Joie, R, de Souza, LC, Rezaii, N, Shir, D, Pijenburg, YAL, Carrillo, MC, Dickerson, BC, Aisen, P, Ossenkoppele, R, Raman, R. Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action. ALZHEIMERS & DEMENTIA. 2026; 22(6)DOI:10.1002/alz.71521. PMID:42334062. IF:11.100(Q1/1D).

Schmidli, L, Richter, I, Thaliyath, S, Frenger, J, Zietz, A, Teller, J, Schuppner, R, Ernst, J, Gabriel, MM, Camps-Renom, P, McCabe, J, Tiedt, S, Johansen, MC, Katan, M, Grosse, GM. Biomarkers of post-stroke cognitive impairment-a systematic literature review. Frontiers in Behavioral Neuroscience. 2026; 20DOI:10.3389/fnbeh.2026.1864277. PMID:42440976. IF:2.900(Q1/1D).

Occhipinti, G, Laudani, C, Jabri, A, Pensotti, F, Leone, PP, Khokhar, AA, Genereux, P, Beneduce, A, Wongpraparut, N, Mangieri, A, Serra, V, Nombela-Franco, L, Sanchez, JS, Asmarats, L, Teles, RC, Chandavimol, M, Romaguera, R, Akodad, M, Cuisset, T, Tayal, R, Algethami, AR, Diaz, JF, Laffond, A, Martin, P, Perez, L, Ruiz-Quevedo, V, Sarno, G, Alvarez, MEV, Assafin, M, García-Gómez, M, Ruberti, A, Sanchis, L, Freixa, X, Maisano, F, Buzzatti, N, Giustino, G, De Backer, O, Latib, A, Amat-Santos, IJ, Villablanca, PA, Regueiro, A. Leaflet Modification to Mitigate Coronary Obstruction Risk During TAVR Results From the LOFTER-TAVR Registry. JACC-Cardiovascular Interventions. 2026; 19(12)DOI:10.1016/j.jcin.2026.05.011. PMID:42331413. IF:11.400(Q1/1D).

Gomes, BF, Sauer, M, Montoliu-Gaya, L, Franquesa-Mullerat, M, Bejanin, A, Alcolea, D, Lleó, A, Illán-Gala, I, Fortea, J, Blennow, K, Zetterberg, H, Nilsson, J, Belbin, O, Ashton, NJ. Cerebrospinal fluid NPTX2/p-tau ratio as a biomarker for cognitive decline in neurodegenerative diseases. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2026; 18(2)DOI:10.1002/dad2.70391. PMID:42326467. IF:(Q/D).

Bravo-Balado, A, Sánchez-Puy, A, Izquierdo, P, Diana, P, Piana, A, Stracci, D, Arena, P, Garcia, SG, Kanashiro, AK, Millán, F, Sánchez-Martín, F, Esquinas, C, Angerri, O, Traxer, O, Palou, J, Emiliani, E. Comparison of TFL and high-power Ho: YAG lasers with multiple pulse modulations: an in vitro study. WORLD JOURNAL OF UROLOGY. 2026; 44(1)DOI:10.1007/s00345-026-06514-x. PMID:42315681. IF:2.900(Q2/3D).

Padilla, C, Zsadanyi, SE, Aragón, I, Morcillo-Nieto, AO, Rubio-Guerra, S, Zhu, NL, Arriola-Infante, JE, Arranz, J, Rodriguez-Baz, I, Maure-Blesa, L, Castro, JG, Barroeta, I, Carmona-Iragui, M, Franquesa-Mullerat, M, Mahant, P, Videla, L, Soriano, LD, Benejam, B, Alcolea, D, Lleó, A, Fortea, J, Santos-Santos, MA, Illán-Gala, I, Sala, I, Sánchez-Saudinós, MB, Bejanin, A. The predictive power of neuropsychological measures in MCI: early detection of dementia conversion. Frontiers in Aging Neuroscience. 2026; 18DOI:10.3389/fnagi.2026.1740033. PMID:42404240. IF:4.500(Q1/2D).

Vilahur, G, Girón, GO, Alcover, S, Padró, T. Primed for metabolic syndrome: evidence of cardiac mitochondrial dysfunction preceding disease. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. 2026; 330(6)DOI:10.1152/ajpheart.00248.2026. PMID:41996108. IF:4.100(Q1/2D).